首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1709695

2025-2029年全球藥物輸送系統市場

Global New Drug Delivery Systems Market 2025-2029

出版日期: 2025年04月16日 | 出版商:

TechNavio | 英文 221 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計 2024 年至 2029 年期間藥物輸送系統市場規模將達 594 億美元，預測期內複合年成長率為 4.6%。

本報告對藥物輸送系統市場進行了全面的分析，包括市場規模、預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了當前市場情景、最新趨勢和促進因素以及整體市場環境的最新分析。慢性病的增加、生技藥品市場的成長以及醫療保健系統的數位化正在推動市場的發展。

市場覆蓋
基準年	2025
年底	2029
預測期	2025-2029
成長動力	加速度
2025與前一年同期比較	4.4%
複合年成長率	4.6%
增量金額	594億美元

研究採用客觀結合一手資料和二手資料的方式進行，其中包括來自業界主要參與者的意見。該報告還提供了主要企業的分析以及按地理分析和供應商格局細分的綜合市場規模資料。該報告包括資料和預測資料。

研究指出，慢性病盛行率的上升是推動未來幾年藥物輸送系統市場成長的主要原因之一。此外，生技藥品市場的成長和醫療保健系統的數位化將導致市場需求龐大。

市場區隔
比較：按給藥途徑
口服給藥系統：2024-2029 年市場規模及預測
注射給藥系統：2024-2029 年市場規模及預測
肺部給藥系統：2024-2029 年市場規模及預測
經經皮給藥系統：2024-2029 年市場規模及預測
其他：2024-2029 年市場規模及預測
按給藥途徑分類的市場機會

第10章依方法分類的市場區隔

市場區隔
比較：依方法
標靶藥物傳遞系統：2024 年至 2029 年市場規模及預測
受管制藥物傳輸系統：2024 年至 2029 年市場規模及預測
調製藥物輸送系統：2024 年至 2029 年市場規模及預測
按方法論分類的市場機會

第11章客戶情況

客戶概覽

第12章地區情勢

地理細分
區域比較
北美：2024-2029 年市場規模及預測
歐洲：2024-2029 年市場規模及預測
亞洲：2024-2029 年市場規模及預測
世界其他地區：2024-2029 年市場規模及預測
美國：市場規模及預測（2024-2029）
德國：2024-2029年市場規模及預測
中國：2024-2029年市場規模及預測
加拿大：2024-2029 年市場規模及預測
日本：2024-2029 年市場規模及預測
英國：2024-2029 年市場規模及預測
法國：2024-2029年市場規模及預測
印度：2024-2029年市場規模及預測
義大利：2024-2029 年市場規模及預測
韓國：2024-2029 年市場規模及預測
按地區分類的市場機會

第13章促進因素、挑戰、機會與限制因素

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機會與限制

第14章競爭格局

概述
競爭格局
令人困惑的情況
產業風險

第15章競爭分析

公司簡介
企業排名指數
公司市場定位
Abbott Laboratories
Amgen Inc.
Antares Pharma Inc.
AstraZeneca Plc
Baxter International Inc.
Becton Dickinson and Co.
Boehringer Ingelheim International GmbH
F. Hoffmann La Roche Ltd.
Gerresheimer AG
Kindeva Drug Delivery LP
Medtronic Plc
Nemera Group
Pfizer Inc.
West Pharmaceutical Services Inc.
Ypsomed Holding AG

第16章附錄

簡介目錄圖表

Product Code: IRTNTR72151

The new drug delivery systems market is forecasted to grow by USD 59.4 bn during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the new drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases, growth in biologics market, and digitalization in healthcare system.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	4.4%
CAGR	4.6%
Incremental Value	$59.4 bn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's new drug delivery systems market is segmented as below:

By Application

Oncology
Neurology
Cardiology
Diabetes
Others

By Route Of Administration

Oral drug delivery systems
Injectable drug delivery systems
Pulmonary drug delivery systems
Transdermal drug delivery systems
Others

By Method

Targeted drug delivery systems
Controlled drug delivery systems
Modulated drug delivery systems

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising prevalence of chronic diseases as one of the prime reasons driving the new drug delivery systems market growth during the next few years. Also, growth in biologics market and digitalization in healthcare system will lead to sizable demand in the market.

The report on the new drug delivery systems market covers the following areas:

New Drug Delivery Systems Market sizing
New Drug Delivery Systems Market forecast
New Drug Delivery Systems Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading new drug delivery systems market vendors that include Abbott Laboratories, Amgen Inc., Antares Pharma Inc., AstraZeneca Plc, Baxter International Inc., Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gerresheimer AG, Gilead Sciences Inc., Kindeva Drug Delivery L.P., Medtronic Plc, Merck KGaA, Nemera Group, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services Inc., and Ypsomed Holding AG. Also, the new drug delivery systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Method
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global New Drug Delivery Systems Market 2019 - 2023
- Historic Market Size - Data Table on Global New Drug Delivery Systems Market 2019 - 2023 ($ billion)
5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ billion)
5.3 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion)
5.4 Method segment analysis 2019 - 2023
- Historic Market Size - Method Segment 2019 - 2023 ($ billion)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

6.1 Impact of AI in the Global New Drug Delivery Systems Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

8.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
8.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ billion)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ billion)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
8.4 Neurology - Market size and forecast 2024-2029
- Chart on Neurology - Market size and forecast 2024-2029 ($ billion)
- Data Table on Neurology - Market size and forecast 2024-2029 ($ billion)
- Chart on Neurology - Year-over-year growth 2024-2029 (%)
- Data Table on Neurology - Year-over-year growth 2024-2029 (%)
8.5 Cardiology - Market size and forecast 2024-2029
- Chart on Cardiology - Market size and forecast 2024-2029 ($ billion)
- Data Table on Cardiology - Market size and forecast 2024-2029 ($ billion)
- Chart on Cardiology - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
8.6 Diabetes - Market size and forecast 2024-2029
- Chart on Diabetes - Market size and forecast 2024-2029 ($ billion)
- Data Table on Diabetes - Market size and forecast 2024-2029 ($ billion)
- Chart on Diabetes - Year-over-year growth 2024-2029 (%)
- Data Table on Diabetes - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)

9 Market Segmentation by Route of Administration

9.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
9.3 Oral drug delivery systems - Market size and forecast 2024-2029
- Chart on Oral drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Data Table on Oral drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Chart on Oral drug delivery systems - Year-over-year growth 2024-2029 (%)
- Data Table on Oral drug delivery systems - Year-over-year growth 2024-2029 (%)
9.4 Injectable drug delivery systems - Market size and forecast 2024-2029
- Chart on Injectable drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Data Table on Injectable drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Chart on Injectable drug delivery systems - Year-over-year growth 2024-2029 (%)
- Data Table on Injectable drug delivery systems - Year-over-year growth 2024-2029 (%)
9.5 Pulmonary drug delivery systems - Market size and forecast 2024-2029
- Chart on Pulmonary drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Data Table on Pulmonary drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Chart on Pulmonary drug delivery systems - Year-over-year growth 2024-2029 (%)
- Data Table on Pulmonary drug delivery systems - Year-over-year growth 2024-2029 (%)
9.6 Transdermal drug delivery systems - Market size and forecast 2024-2029
- Chart on Transdermal drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Data Table on Transdermal drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Chart on Transdermal drug delivery systems - Year-over-year growth 2024-2029 (%)
- Data Table on Transdermal drug delivery systems - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ billion)
- Data Table on Market opportunity by Route of Administration ($ billion)

10 Market Segmentation by Method

10.1 Market segments
- Chart on Method - Market share 2024-2029 (%)
- Data Table on Method - Market share 2024-2029 (%)
10.2 Comparison by Method
- Chart on Comparison by Method
- Data Table on Comparison by Method
10.3 Targeted drug delivery systems - Market size and forecast 2024-2029
- Chart on Targeted drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Data Table on Targeted drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Chart on Targeted drug delivery systems - Year-over-year growth 2024-2029 (%)
- Data Table on Targeted drug delivery systems - Year-over-year growth 2024-2029 (%)
10.4 Controlled drug delivery systems - Market size and forecast 2024-2029
- Chart on Controlled drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Data Table on Controlled drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Chart on Controlled drug delivery systems - Year-over-year growth 2024-2029 (%)
- Data Table on Controlled drug delivery systems - Year-over-year growth 2024-2029 (%)
10.5 Modulated drug delivery systems - Market size and forecast 2024-2029
- Chart on Modulated drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Data Table on Modulated drug delivery systems - Market size and forecast 2024-2029 ($ billion)
- Chart on Modulated drug delivery systems - Year-over-year growth 2024-2029 (%)
- Data Table on Modulated drug delivery systems - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Method
- Market opportunity by Method ($ billion)
- Data Table on Market opportunity by Method ($ billion)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.12 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
15.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
15.6 Antares Pharma Inc.
- Antares Pharma Inc. - Overview
- Antares Pharma Inc. - Product / Service
- Antares Pharma Inc. - Key offerings
- SWOT
15.7 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
15.8 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
15.9 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
15.10 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
15.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.12 Gerresheimer AG
- Gerresheimer AG - Overview
- Gerresheimer AG - Business segments
- Gerresheimer AG - Key news
- Gerresheimer AG - Key offerings
- Gerresheimer AG - Segment focus
- SWOT
15.13 Kindeva Drug Delivery L.P.
- Kindeva Drug Delivery L.P. - Overview
- Kindeva Drug Delivery L.P. - Product / Service
- Kindeva Drug Delivery L.P. - Key offerings
- SWOT
15.14 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
15.15 Nemera Group
- Nemera Group - Overview
- Nemera Group - Product / Service
- Nemera Group - Key offerings
- SWOT
15.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.17 West Pharmaceutical Services Inc.
- West Pharmaceutical Services Inc. - Overview
- West Pharmaceutical Services Inc. - Business segments
- West Pharmaceutical Services Inc. - Key offerings
- West Pharmaceutical Services Inc. - Segment focus
- SWOT
15.18 Ypsomed Holding AG
- Ypsomed Holding AG - Overview
- Ypsomed Holding AG - Business segments
- Ypsomed Holding AG - Key offerings
- Ypsomed Holding AG - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Market Segmentation by Method
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global New Drug Delivery Systems Market 2019 - 2023 ($ billion)
Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ billion)
Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion)
Exhibits28: Historic Market Size - Method Segment 2019 - 2023 ($ billion)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Application - Market share 2024-2029 (%)
Exhibits39: Data Table on Application - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Application
Exhibits41: Data Table on Comparison by Application
Exhibits42: Chart on Oncology - Market size and forecast 2024-2029 ($ billion)
Exhibits43: Data Table on Oncology - Market size and forecast 2024-2029 ($ billion)
Exhibits44: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Neurology - Market size and forecast 2024-2029 ($ billion)
Exhibits47: Data Table on Neurology - Market size and forecast 2024-2029 ($ billion)
Exhibits48: Chart on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Cardiology - Market size and forecast 2024-2029 ($ billion)
Exhibits51: Data Table on Cardiology - Market size and forecast 2024-2029 ($ billion)
Exhibits52: Chart on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits54: Chart on Diabetes - Market size and forecast 2024-2029 ($ billion)
Exhibits55: Data Table on Diabetes - Market size and forecast 2024-2029 ($ billion)
Exhibits56: Chart on Diabetes - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Diabetes - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits62: Market opportunity by Application ($ billion)
Exhibits63: Data Table on Market opportunity by Application ($ billion)
Exhibits64: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits65: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits66: Chart on Comparison by Route of Administration
Exhibits67: Data Table on Comparison by Route of Administration
Exhibits68: Chart on Oral drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits69: Data Table on Oral drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits70: Chart on Oral drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Oral drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits72: Chart on Injectable drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits73: Data Table on Injectable drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits74: Chart on Injectable drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on Injectable drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits76: Chart on Pulmonary drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits77: Data Table on Pulmonary drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits78: Chart on Pulmonary drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits79: Data Table on Pulmonary drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits80: Chart on Transdermal drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits81: Data Table on Transdermal drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits82: Chart on Transdermal drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits83: Data Table on Transdermal drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits84: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits85: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits86: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits87: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits88: Market opportunity by Route of Administration ($ billion)
Exhibits89: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits90: Chart on Method - Market share 2024-2029 (%)
Exhibits91: Data Table on Method - Market share 2024-2029 (%)
Exhibits92: Chart on Comparison by Method
Exhibits93: Data Table on Comparison by Method
Exhibits94: Chart on Targeted drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits95: Data Table on Targeted drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits96: Chart on Targeted drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits97: Data Table on Targeted drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits98: Chart on Controlled drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits99: Data Table on Controlled drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits100: Chart on Controlled drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits101: Data Table on Controlled drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits102: Chart on Modulated drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits103: Data Table on Modulated drug delivery systems - Market size and forecast 2024-2029 ($ billion)
Exhibits104: Chart on Modulated drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits105: Data Table on Modulated drug delivery systems - Year-over-year growth 2024-2029 (%)
Exhibits106: Market opportunity by Method ($ billion)
Exhibits107: Data Table on Market opportunity by Method ($ billion)
Exhibits108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits109: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits110: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits111: Chart on Geographic comparison
Exhibits112: Data Table on Geographic comparison
Exhibits113: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits114: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits115: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits118: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits119: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits122: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits123: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits126: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits127: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits130: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits131: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits142: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits143: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits146: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits147: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits150: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits151: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits154: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits155: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits157: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits158: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits159: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits160: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits161: Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits162: Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits163: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits164: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits165: Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits166: Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits167: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits168: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits169: Market opportunity By Geographical Landscape ($ billion)
Exhibits170: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits171: Impact of drivers and challenges in 2024 and 2029
Exhibits172: Overview on criticality of inputs and factors of differentiation
Exhibits173: Overview on factors of disruption
Exhibits174: Impact of key risks on business
Exhibits175: Companies covered
Exhibits176: Company ranking index
Exhibits177: Matrix on companies position and classification
Exhibits178: Abbott Laboratories - Overview
Exhibits179: Abbott Laboratories - Business segments
Exhibits180: Abbott Laboratories - Key news
Exhibits181: Abbott Laboratories - Key offerings
Exhibits182: Abbott Laboratories - Segment focus
Exhibits183: SWOT
Exhibits184: Amgen Inc. - Overview
Exhibits185: Amgen Inc. - Product / Service
Exhibits186: Amgen Inc. - Key news
Exhibits187: Amgen Inc. - Key offerings
Exhibits188: SWOT
Exhibits189: Antares Pharma Inc. - Overview
Exhibits190: Antares Pharma Inc. - Product / Service
Exhibits191: Antares Pharma Inc. - Key offerings
Exhibits192: SWOT
Exhibits193: AstraZeneca Plc - Overview
Exhibits194: AstraZeneca Plc - Product / Service
Exhibits195: AstraZeneca Plc - Key news
Exhibits196: AstraZeneca Plc - Key offerings
Exhibits197: SWOT
Exhibits198: Baxter International Inc. - Overview
Exhibits199: Baxter International Inc. - Business segments
Exhibits200: Baxter International Inc. - Key news
Exhibits201: Baxter International Inc. - Key offerings
Exhibits202: Baxter International Inc. - Segment focus
Exhibits203: SWOT
Exhibits204: Becton Dickinson and Co. - Overview
Exhibits205: Becton Dickinson and Co. - Business segments
Exhibits206: Becton Dickinson and Co. - Key news
Exhibits207: Becton Dickinson and Co. - Key offerings
Exhibits208: Becton Dickinson and Co. - Segment focus
Exhibits209: SWOT
Exhibits210: Boehringer Ingelheim International GmbH - Overview
Exhibits211: Boehringer Ingelheim International GmbH - Product / Service
Exhibits212: Boehringer Ingelheim International GmbH - Key news
Exhibits213: Boehringer Ingelheim International GmbH - Key offerings
Exhibits214: SWOT
Exhibits215: F. Hoffmann La Roche Ltd. - Overview
Exhibits216: F. Hoffmann La Roche Ltd. - Business segments
Exhibits217: F. Hoffmann La Roche Ltd. - Key news
Exhibits218: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits219: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits220: SWOT
Exhibits221: Gerresheimer AG - Overview
Exhibits222: Gerresheimer AG - Business segments
Exhibits223: Gerresheimer AG - Key news
Exhibits224: Gerresheimer AG - Key offerings
Exhibits225: Gerresheimer AG - Segment focus
Exhibits226: SWOT
Exhibits227: Kindeva Drug Delivery L.P. - Overview
Exhibits228: Kindeva Drug Delivery L.P. - Product / Service
Exhibits229: Kindeva Drug Delivery L.P. - Key offerings
Exhibits230: SWOT
Exhibits231: Medtronic Plc - Overview
Exhibits232: Medtronic Plc - Business segments
Exhibits233: Medtronic Plc - Key news
Exhibits234: Medtronic Plc - Key offerings
Exhibits235: Medtronic Plc - Segment focus
Exhibits236: SWOT
Exhibits237: Nemera Group - Overview
Exhibits238: Nemera Group - Product / Service
Exhibits239: Nemera Group - Key offerings
Exhibits240: SWOT
Exhibits241: Pfizer Inc. - Overview
Exhibits242: Pfizer Inc. - Product / Service
Exhibits243: Pfizer Inc. - Key news
Exhibits244: Pfizer Inc. - Key offerings
Exhibits245: SWOT
Exhibits246: West Pharmaceutical Services Inc. - Overview
Exhibits247: West Pharmaceutical Services Inc. - Business segments
Exhibits248: West Pharmaceutical Services Inc. - Key offerings
Exhibits249: West Pharmaceutical Services Inc. - Segment focus
Exhibits250: SWOT
Exhibits251: Ypsomed Holding AG - Overview
Exhibits252: Ypsomed Holding AG - Business segments
Exhibits253: Ypsomed Holding AG - Key offerings
Exhibits254: Ypsomed Holding AG - Segment focus
Exhibits255: SWOT
Exhibits256: Inclusions checklist
Exhibits257: Exclusions checklist
Exhibits258: Currency conversion rates for US$
Exhibits259: Research methodology
Exhibits260: Information sources
Exhibits261: Data validation
Exhibits262: Validation techniques employed for market sizing
Exhibits263: Data synthesis
Exhibits264: 360 degree market analysis
Exhibits265: List of abbreviations